Your browser doesn't support javascript.
loading
Observational study investigating the level of support from a convolutional neural network in face and scalp lesions deemed diagnostically 'unclear' by dermatologists.
Kommoss, Katharina S; Winkler, Julia K; Mueller-Christmann, Christine; Bardehle, Felicitas; Toberer, Ferdinand; Stolz, Wilhelm; Kraenke, Teresa; Hofmann-Wellenhof, Rainer; Blum, Andreas; Enk, Alexander; Rosenberger, Albert; Haenssle, Holger A.
Afiliación
  • Kommoss KS; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Winkler JK; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Mueller-Christmann C; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Bardehle F; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Toberer F; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Stolz W; Department of Dermatology, Allergology and Environmental Medicine II, Hospital Thalkirchner Street, Munich, Germany.
  • Kraenke T; Department of Dermatology and Venerology, Medical University of Graz, Graz, Austria.
  • Hofmann-Wellenhof R; Department of Dermatology and Venerology, Medical University of Graz, Graz, Austria.
  • Blum A; Public, Private and Teaching Practice of Dermatology, Konstanz, Germany.
  • Enk A; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Rosenberger A; Department of Genetic Epidemiology, University of Goettingen, Goettingen, Germany.
  • Haenssle HA; Department of Dermatology, University of Heidelberg, Heidelberg, Germany. Electronic address: Holger.Haenssle@med.uni-heidelberg.de.
Eur J Cancer ; 185: 53-60, 2023 05.
Article en En | MEDLINE | ID: mdl-36963352
ABSTRACT

BACKGROUND:

The clinical diagnosis of face and scalp lesions (FSL) is challenging due to overlapping features. Dermatologists encountering diagnostically 'unclear' lesions may benefit from artificial intelligence support via convolutional neural networks (CNN).

METHODS:

In a web-based classification task, dermatologists (n = 64) diagnosed a convenience sample of 100 FSL as 'benign', 'malignant', or 'unclear' and indicated their management decisions ('no action', 'follow-up', 'treatment/excision'). A market-approved CNN (Moleanalyzer-Pro®, FotoFinder Systems, Germany) was applied for binary classifications (benign/malignant) of dermoscopic images.

RESULTS:

After reviewing one dermoscopic image per case, dermatologists labelled 562 of 6400 diagnoses (8.8%) as 'unclear' and mostly managed these by follow-up examinations (57.3%, n = 322) or excisions (42.5%, n = 239). Management was incorrect in 58.8% of 291 truly malignant cases (171 'follow-up' or 'no action') and 43.9% of 271 truly benign cases (119 'excision'). Accepting CNN classifications in unclear cases would have reduced false management decisions to 4.1% in truly malignant and 31.7% in truly benign lesions (both p < 0.01). After receiving full case information 239 diagnoses (3.7%) remained 'unclear' to dermatologists, now triggering more excisions (72.0%) than follow-up examinations (28.0%). These management decisions were incorrect in 32.8% of 116 truly malignant cases and 76.4% of 123 truly benign cases. Accepting CNN classifications would have reduced false management decisions to 6.9% in truly malignant lesions and to 38.2% in truly benign cases (both p < 0.01).

CONCLUSIONS:

Dermatologists mostly managed diagnostically 'unclear' FSL by treatment/excision or follow-up examination. Following CNN classifications as guidance in unclear cases seems suitable to significantly reduce incorrect decisions.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania